New Antibodies and Kits for mTOR Pathway
Mammalian Target of Rapamycin (mTOR) was originally identified in Saccharomyces cerevisiae, is a large class IV PI-3 kinase family member . mTOR integrates mitogenic and nutrient signals to regulate cell growth, metabolism, and survival. Biomarkers indicate that the mTOR pathway is hyperactive in certain types of cancers, suggesting mTOR as a potential target for cancer therapy. Choose Calbiochem as your provider of reagents to study the mTOR and other signaling pathways.
|
